Skip to main content
. 2017 Apr 19;12(1):43. doi: 10.1007/s11657-017-0324-5

Table 3.

Effect of approved interventions for glucocorticoid-induced osteoporosis on BMD and fracture risk

Intervention Spine BMD Hip BMD Vertebral fracture Non-vertebral fracture
Alendronate A A Bb NAE
Risedronate A A Ab NAE
Teriparatide Aa Aa Aa, b NAE
Zoledronic acid Aa Aa NAE NAE

A grade A recommendation, B grade B recommendation, NAE not adequately evaluated

aComparator study

bNot a primary endpoint